Besides, OPA1 overexpression displays more resistance to cisplatin treatment in lung adenocarcinoma cells (25), whereas OPA1 downregulation promotes the release of cytochrome c, thus inducing apoptosis and attenuating the cisplatin resistance (26). Here, CYCS is linked to lung adenocarcinoma.